Targeted Biomarker Profiling of Matched Primary and Metastatic Estrogen Receptor Positive Breast Cancers

Patients with newly diagnosed, early stage estrogen receptor positive (ER+) breast cancer often show disease free survival in excess of five years following surgery and systemic adjuvant therapy. An important question is whether diagnostic tumor tissue from the primary lesion offers an accurate mole...

Descripción completa

Detalles Bibliográficos
Autores principales: Schleifman, Erica B., Desai, Rupal, Spoerke, Jill M., Xiao, Yuanyuan, Wong, Cheryl, Abbas, Ilma, O’Brien, Carol, Patel, Rajesh, Sumiyoshi, Teiko, Fu, Ling, Tam, Rachel N., Koeppen, Hartmut, Wilson, Timothy R., Raja, Rajiv, Hampton, Garret M., Lackner, Mark R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3919784/
https://www.ncbi.nlm.nih.gov/pubmed/24520381
http://dx.doi.org/10.1371/journal.pone.0088401

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3919784/
https://www.ncbi.nlm.nih.gov/pubmed/24520381
http://dx.doi.org/10.1371/journal.pone.0088401

Ejemplares similares